OncoQuest Completes US$6 Million Private Placement

OncoQuest, an Edmonton-based biopharmaceutical company, completed a private placement financing that raised US$6.03 million. OncoQuest focuses on the development and commercialization of immunotherapic products for the treatment of cancer, and it intends to use the proceeds of the placement for further development of Oregovomab, its lead compound. A South Korean institutional fund led this private placement. 

Use 'AND' or 'OR' to refine your search.

Use quotes " " to get exact matches or remove them to get more results.